Jones Hill Capital LP: TREVI THERAPEUTICS INC (TRVI): Quarterly 13F Position History
As of Q2 2026, Jones Hill Capital LP reported 1,339,212 shares of TREVI THERAPEUTICS INC (TRVI), worth $25.0M and representing 5.3% of its 13F equity book. Quarter-over-quarter share count change: + 969,037 (+261.8%) . The position first appeared in Q1 2026 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 1,339,212Shares Held (Latest Filing)
- $25.0MReported Market Value (Latest Filing)
- 5.3%Portfolio Weight (% of 13F Equity Book)
- +969,037Quarter-over-Quarter Share Change
- +$20.6MQuarter-over-Quarter Value Change
- 1,339,212Peak Reported Shares (Historical)
Recent initiation: Jones Hill Capital LP first reported TRVI on the Q1 2026 filing, so fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,339,212 | +969,037 | +261.8% | $25.0M | 5.3% | $18.6 |
| Q1 2026 | 370,175 | – | – | $4.4M | 0.9% | $11.9 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Jones Hill Capital LP first disclose a TRVI position in 13F-HR filings?
Jones Hill Capital LP first reported TREVI THERAPEUTICS INC (TRVI) on its 13F-HR filing for the period ending 2026-03-31 (Q1 2026). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Jones Hill Capital LP's most recent quarter-over-quarter share-count change in TRVI?
Between Q1 2026 and Q2 2026, Jones Hill Capital LP added 969,037 shares of TRVI (+261.8%), bringing the total reported position to 1,339,212 shares at a market value of $25.0M.
Does the implied price-per-share represent Jones Hill Capital LP's cost basis in TRVI?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.